Literature DB >> 12667094

Macrophage migration inhibitory factor.

Elias Lolis1, Richard Bucala.   

Abstract

Macrophage migration inhibitory factor (MIF) is a ubiquitous protein that is found in virtually all cells. Its precise function in the majority of cells is not known, but studies performed over the last decade indicate that it is a critical upstream regulator of the innate and acquired immune response. MIF is released under a variety of circumstances, regulates cytokine secretion and the expression of receptors that are involved in innate immunity, inhibits p53 function, and activates components of the mitogen-activated protein kinase and Jun-activation domain-binding protein-1 (Jab-1) pathways. Compelling in vitro and in vivo evidence has focused attention on this protein as a new therapeutic target for inflammatory and autoimmune diseases. Unique structural features, including an intrinsic catalytic activity, offer attractive opportunities for the discovery and design of therapeutic MIF inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667094     DOI: 10.1517/14728222.7.2.153

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  40 in total

1.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Authors:  Yoonsang Cho; Gregg V Crichlow; Jon J Vermeire; Lin Leng; Xin Du; Michael E Hodsdon; Richard Bucala; Michael Cappello; Matt Gross; Federico Gaeta; Kirk Johnson; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

2.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

3.  Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.

Authors:  Doreen Nazeih Assaad Younan; Naglaa Agamia; Adel Elshafei; Nancy Ebeid
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

4.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

Authors:  Xuerong Shi; Lin Leng; Tian Wang; Wenkui Wang; Xin Du; Ji Li; Courtney McDonald; Zun Chen; James W Murphy; Elias Lolis; Paul Noble; Warren Knudson; Richard Bucala
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

5.  Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.

Authors:  Qinbo Yuan; Meilin Wang; Miaomiao Wang; Zhengdong Zhang; Wei Zhang
Journal:  Mol Biol Rep       Date:  2011-07-13       Impact factor: 2.316

Review 6.  The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.

Authors:  Bong-Sung Kim; Norbert Pallua; Jürgen Bernhagen; Richard Bucala
Journal:  Exp Mol Med       Date:  2015-05-01       Impact factor: 8.718

7.  Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.

Authors:  Chengjie Xiong; Bo Huang; Yanping Cun; Bayan G Aghdasi; Yue Zhou
Journal:  Clin Orthop Relat Res       Date:  2014-02-26       Impact factor: 4.176

8.  Spirohexenolide A targets human macrophage migration inhibitory factor (hMIF).

Authors:  Wei-Lun Yu; Brian D Jones; Minjin Kang; Justin C Hammons; James J La Clair; Michael D Burkart
Journal:  J Nat Prod       Date:  2013-05-09       Impact factor: 4.050

9.  Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation.

Authors:  Biji Mathew; Jeffrey R Jacobson; Jessica H Siegler; Jaideep Moitra; Michael Blasco; Lishi Xie; Crystal Unzueta; Tong Zhou; Carrie Evenoski; Mohammed Al-Sakka; Rajesh Sharma; Ben Huey; Aydogan Bulent; Brett Smith; Sundararajan Jayaraman; Narsa M Reddy; Shekhar P Reddy; Günter Fingerle-Rowson; Richard Bucala; Steven M Dudek; Viswanathan Natarajan; Ralph R Weichselbaum; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

10.  Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.

Authors:  Katherine L Meyer-Siegler; Jacob Cox; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  Cancer Lett       Date:  2009-09-16       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.